Holdings of HARTFORD HEALTHCARE HLS FUND
HARTFORD SERIES FUND INC · Original filing · Compare with another fund · Report an error
- Net assets
- 112.4M $ including 108.8M $ in equities, 96.8 %
- Positions
- 76 in 9 countries
- Top ten
- 48.1 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 11,684 | 14M $ | 12.47 % |
| 2 | Johnson & Johnson | 29,313 | 7.4M $ | 6.63 % |
| 3 | Merck & Co Inc | 57,698 | 7.4M $ | 6.60 % |
| 4 | UnitedHealth Group Inc | 12,747 | 5.3M $ | 4.72 % |
| 5 | AbbVie Inc | 15,306 | 3.9M $ | 3.43 % |
| 6 | Intuitive Surgical Inc | 8,447 | 3.4M $ | 2.99 % |
| 7 | Elevance Health Inc | 8,597 | 3.3M $ | 2.96 % |
| 8 | CVS Health Corp | 31,846 | 3.3M $ | 2.93 % |
| 9 | Vertex Pharmaceuticals Inc | 6,088 | 3M $ | 2.69 % |
| 10 | Danaher Corp | 15,625 | 3M $ | 2.65 % |
| 11 | Edwards Lifesciences Corp | 30,064 | 2.7M $ | 2.42 % |
| 12 | Abbott Laboratories | 25,958 | 2.4M $ | 2.10 % |
| 13 | Cencora Inc | 8,209 | 2.3M $ | 2.07 % |
| 14 | Cardinal Health Inc | 8,573 | 2M $ | 1.81 % |
| 15 | Thermo Fisher Scientific Inc | 3,678 | 1.8M $ | 1.64 % |
| 16 | HCA Healthcare Inc | 4,608 | 1.8M $ | 1.60 % |
| 17 | Regeneron Pharmaceuticals Inc | 2,742 | 1.7M $ | 1.52 % |
| 18 | Biogen Inc | 7,312 | 1.6M $ | 1.41 % |
| 19 | Agilent Technologies Inc | 11,491 | 1.5M $ | 1.36 % |
| 20 | GSK PLC | 51,586 | 1.4M $ | 1.21 % |
| 21 | Boston Scientific Corp | 31,220 | 1.3M $ | 1.19 % |
| 22 | Stryker Corp | 4,189 | 1.3M $ | 1.17 % |
| 23 | Centene Corp | 20,353 | 1.3M $ | 1.16 % |
| 24 | Medtronic PLC | 14,617 | 1.1M $ | 1.02 % |
| 25 | United Therapeutics Corp | 1,984 | 1.1M $ | 0.96 % |
| 26 | Incyte Corp | 9,271 | 1.1M $ | 0.94 % |
| 27 | Dexcom Inc | 15,255 | 1M $ | 0.91 % |
| 28 | Argenx SE | 1,011 | 938K $ | 0.83 % |
| 29 | UCB SA | 2,992 | 895.7K $ | 0.80 % |
| 30 | IONIS PHARMACEUTICALS INC | 11,237 | 891K $ | 0.79 % |
| 31 | STERIS PLC | 4,043 | 851.3K $ | 0.76 % |
| 32 | Ascendis Pharma A/S | 3,191 | 851.1K $ | 0.76 % |
| 33 | Madrigal Pharmaceuticals Inc | 1,541 | 827.4K $ | 0.74 % |
| 34 | CYTOKINETICS INC | 9,655 | 822.5K $ | 0.73 % |
| 35 | PTC Therapeutics Inc | 9,817 | 800.8K $ | 0.71 % |
| 36 | ALNYLAM PHARMACEUTICALS INC | 2,629 | 791.4K $ | 0.70 % |
| 37 | REVOLUTION MEDICINES INC | 4,177 | 782.3K $ | 0.70 % |
| 38 | ELANCO ANIMAL HEALTH INC | 31,004 | 763K $ | 0.68 % |
| 39 | Bristol-Myers Squibb Co | 12,812 | 738.2K $ | 0.66 % |
| 40 | Protagonist Therapeutics Inc | 5,818 | 713.2K $ | 0.63 % |
| 41 | ARCUS BIOSCIENCES INC | 22,493 | 693.5K $ | 0.62 % |
| 42 | AstraZeneca PLC | 3,643 | 690.8K $ | 0.61 % |
| 43 | Galderma Group AG | 2,916 | 663.2K $ | 0.59 % |
| 44 | Dianthus Therapeutics Inc | 6,614 | 644.7K $ | 0.57 % |
| 45 | KYMERA THERAPEUTICS INC | 5,448 | 624.7K $ | 0.56 % |
| 46 | Amgen Inc | 1,716 | 621.4K $ | 0.55 % |
| 47 | Bridgebio Pharma Inc | 8,299 | 618.1K $ | 0.55 % |
| 48 | Pharvaris NV | 17,554 | 607K $ | 0.54 % |
| 49 | Encompass Health Corp | 5,857 | 592K $ | 0.53 % |
| 50 | Disc Medicine Inc | 7,887 | 576.9K $ | 0.51 % |
| 51 | ICON PLC | 3,282 | 570.1K $ | 0.51 % |
| 52 | Adaptive Biotechnologies Corp | 25,570 | 548.5K $ | 0.49 % |
| 53 | STRUCTURE THERAPEUTICS INC | 10,133 | 543.8K $ | 0.48 % |
| 54 | Scholar Rock Holding Corp | 9,781 | 538K $ | 0.48 % |
| 55 | HeartFlow Inc | 17,989 | 527.8K $ | 0.47 % |
| 56 | MIRUM PHARMACEUTICALS INC | 4,437 | 519.4K $ | 0.46 % |
| 57 | ALIGNMENT HEALTHCARE INC | 21,135 | 503.2K $ | 0.45 % |
| 58 | Immunocore Holdings PLC | 15,428 | 489.8K $ | 0.44 % |
| 59 | Option Care Health Inc | 23,096 | 484.3K $ | 0.43 % |
| 60 | VAXCYTE INC | 8,272 | 480.9K $ | 0.43 % |
| 61 | Celldex Therapeutics Inc | 12,896 | 479.9K $ | 0.43 % |
| 62 | QIAGEN NV | 11,870 | 464.1K $ | 0.41 % |
| 63 | Kailera Therapeutics Inc | 19,352 | 426.3K $ | 0.38 % |
| 64 | CG ONCOLOGY INC | 5,942 | 422.2K $ | 0.38 % |
| 65 | Trevi Therapeutics Inc | 21,888 | 408.2K $ | 0.36 % |
| 66 | Acadia Healthcare Co Inc | 13,029 | 384.7K $ | 0.34 % |
| 67 | Stoke Therapeutics Inc | 10,840 | 354.7K $ | 0.32 % |
| 68 | Immunome Inc | 16,589 | 351.5K $ | 0.31 % |
| 69 | JIANGSU HENGRUI PHARMACEUTICALS CO LTD | 45,725 | 338.3K $ | 0.30 % |
| 70 | Definium Therapeutics Inc | 7,100 | 334K $ | 0.30 % |
| 71 | Inspire Medical Systems Inc | 7,432 | 331.5K $ | 0.30 % |
| 72 | GenFleet Therapeutics Shanghai Inc | 83,000 | 313.7K $ | 0.28 % |
| 73 | Crinetics Pharmaceuticals Inc | 6,881 | 257.5K $ | 0.23 % |
| 74 | AVALYN PHARMA INC | 2,500 | 82.3K $ | 0.07 % |
| 75 | Alebund Pharmaceuticals Jiangsu Ltd | 12,300 | 72K $ | 0.06 % |
| 76 | Alamar Biosciences Inc | 1,300 | 35.2K $ | 0.03 % |
Sector breakdown
- Health care 79.6 %
- Unattributed 20.4 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 96.7 %
- GBP 1.2 %
- EUR 0.8 %
- HKD 0.7 %
- CHF 0.6 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 93.3 %
- United Kingdom 1.9 %
- Netherlands 1.4 %
- Belgium 0.8 %
- Denmark 0.8 %
- Switzerland 0.6 %
- Hong Kong SAR China 0.6 %
- Ireland 0.5 %
- China 0.1 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 65 | 101.5M $ | 93.29 % |
| 2 | United Kingdom | 2 | 2M $ | 1.88 % |
| 3 | Netherlands | 2 | 1.5M $ | 1.42 % |
| 4 | Belgium | 1 | 895.7K $ | 0.82 % |
| 5 | Denmark | 1 | 851.1K $ | 0.78 % |
| 6 | Switzerland | 1 | 663.2K $ | 0.61 % |
| 7 | Hong Kong SAR China | 2 | 652K $ | 0.60 % |
| 8 | Ireland | 1 | 570.1K $ | 0.52 % |
| 9 | China | 1 | 72K $ | 0.07 % |
Cite this page
Titelia. "Holdings of HARTFORD HEALTHCARE HLS FUND". https://titelia.com/en/funds/S000003206